By Scott Meacham There is very big news this month for individuals and families affected by sickle cell disease (SCD). The U.S. Food and Drug Administration (FDA) has approved the first targeted treatment to reduce the frequency of pain crises in individuals living with SCD. This new drug — Adakveo® from Novartis — decreases theRead more
By Scott Meacham This time of year, Christmas music is everywhere. Some people get a little tired of it, but for me it’s all part of the season, and I like it. Christmas music reminds me of family, friends, and memories of Christmas mornings and meals. The other day, I was on an errand, andRead more
By Stephen Prescott, M.D. When Novartis announced earlier this month that the U.S. Food and Drug Administration had approved the company’s new drug to treat sickle cell anemia, the press release didn’t mention Oklahoma. But it should have. That drug, known as Adakveo, is as Oklahoman as redbuds and scissor-tailed flycatchers. Indeed, but for workRead more
By Scott Meacham Recently, when Elliott Adams, author of The Startup Mixtape: The Guide to Building and Launching a High-Growth Technology Startup signed up for i2E’s Venture Assessment Program (VAP), it was a great opportunity for us to gain perspective from an industry pro. Elliott’s book is based on his broad experience in entrepreneurship. HeRead more
By Scott Meacham When Younghwa “Henry” Shin, Ph.D., a co-founder and CEO of Excitant Therapeutics entered graduate school at the University of Oklahoma Health Sciences Center (OUHSC), his interest was neuroscience. Then, during a year of rotation structured to give students a taste of different projects and specialties, he was assigned to Dr. Jian-Xing (Jay)Read more
By Scott Meacham Growing up I used to love to listen to Paul Harvey’s The Rest of the Story on the radio. The nuances he would bring to light with just a little deeper look were fascinating. After reading Dale Denwalt’s column in the Oklahoman (October 20) headlined “Insiders Report Flaws in State Startup Ecosystem,”Read more
By Jim Stafford Once a year, the Oklahoma Center for the Advancement of Science and Technology (OCAST) gathers scientists from across the state who are currently receiving funding from its health research program in a sort of show-and-tell educational event. Recently, about 100 OCAST-funded life science researchers assembled at the Samis Family Education Center onRead more
By Scott Meacham Successful entrepreneurs and innovators are passionate. They know their products inside out. They are driven to ask for feedback and then to listen as their customers describe what they like and what they don’t. They are evangelists for the industry they represent. When that industry is the beverage industry, savvy entrepreneurs knowRead more
By Scott Meacham When I set out last week to write about Aevus Precision Diagnostics, it was because this early stage startup has a compelling concept for tackling type 2 diabetes (T2D). As I heard more about Aevus co-founders — Puneet Chadha and Yash Sagar Santani — I recognized that their story is also aRead more
By Scott Meacham Diabetes is at an all-time high. An estimated 30 million people in the U.S. (about one in ten) are living with this chronic, incurable disease. Type 2 diabetes (T2D) is most common. More than 20 million people have this condition which can contribute to heart attack and stroke, vison loss and blindness,Read more
